Evaluation of renal function and damage: A laboratorial challenge;Avaliação da função e da lesão renal: Um desafio laboratorial

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 43, Issue 5, 2007, Pages 329-337

  Sodré, Fábio L ^a,b   Costa, Josete Conceição Barreto ^a   Lima, José Carlos C ^a  

^a Hospital de Beneficência Portuguesa   (Brazil)

^b Laboratório de Patologia Clínica Instituto Cárdio Pulmonar   (Brazil)

Author keywords

Glomerular filtration rate; Laboratorial tests; Renal damage; Renal function

Indexed keywords

EID: 37349064931     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. JAFFE, M. Z. Methods determining creatinine. Physiol Chem, v. 10, p. 39-40, 1886.
2. LEITE, I.C. et al. Comparação das informações sobre as prevalências de doenças crônicas obtidas pelo suplemento saúde da PNAD/98 e as estimadas pelo estudo Carga de Doença no Brasil. Ciênc Saúde Coletiva, v. 7, n. 4, p. 733-41, 2002.
3. CORESH, J. et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol, v. 16, p. 180-88, 2005.
4. BURTIS, C.A.; ASHWOOD, E.R. Clinical Chemistry. Philadelphia: Saunders, 1999.
5. LEVEY, A.S.; STEVENS L.A.; HOSTETTER, T. Automatic reporting of estimated glomerular filtration rate: just what the doctor ordered. Clin Chem, v. 52, n. 12, p. 2188-93, 2006.
6. RAINEY, P.M. Automatic reporting of estimated glomerular filtration rate: jumping the gun? Clin Chem, v. 52, n. 12, p. 2184-87, 2006.
7. VASILIADES, J. Reaction of alkaline sodium picrate with creatinine: I. Kinetics and mechanism of formation of the mono-creatinine picric acid complex. Clin Chem, v. 22, p. 1664-71, 1976.
8. BOWERS, L. D. Kinetic serum creatinine assays I. The role of various factors in determining specificity. Clin Chem, v. 26, p. 551-4, 1980.
9. SWAIN, R.R.; BRIGGS, S.L. Positive interference with the Jaffe reaction by cephalosporin antibiotics. Clin Chem, v. 23, p. 1340-42, 1977.
10. WATKINS, P.J. The effect of ketone bodies on the determination of creatinine. Clin Chim Acta, v. 18, n. 2, p. 191-96, 1967.
11. SPAYD, R.W. et al. Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem, v. 24, p. 1343-50, 1978.
12. GRAY, M.R. et al. Evaluation of a rapid specific ward based assay for creatinine in blood. Clin Nephrol, v. 43, n. 3, p. 169-73, 1995.
13. ABRAHAMSON, M. et al. Structure and expression of the human cystatin C gene. Biochem J, v. 268, p. 287-94, 1990.
14. GRUBB, A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol, v. 38, p. S20-S27, 1992.
15. NORLUND, L. et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum β2- microglobulin/cystatin C-ratio. Scand J Clin Lab Invest, v. 57, p. 463-70, 1997.
16. ERLANDSEN, E.J.; RANDERS, E.; KRISTENSEN, J.H. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med, v. 36, p. 393-97, 1998.
17. FINNEY, H.; NEWMAN, D.J.; PRICE, C.P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem, v. 37, p. 49-59, 2000.
18. FLISER, D.; RITZ, E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis, v. 37, p. 79-83, 2001.
19. HERGET-ROSENTHAL, S. et al. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol, v. 20, p. 97-102, 2000.
20. LE BRICON, T. et al. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem, v. 45, p. 2243-49, 1999.
21. WOITAS, R.P. et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem, v. 46, p. 712-14, 2000.
22. TOMINO, Y. et al. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal, v. 15, p. 25-29, 2001.
23. MANGGE, H. et al. Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis. Clin Chim Acta, v. 300, p. 195-202, 2000.
24. CAREGARO, L. et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med, v. 154, p. 201-05, 1994.
25. HARMOINEN, A. et al. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol, v. 15, p. 105-08, 2000.
26. FINNEY, H. et al. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child, v. 82, p. 71-75, 2000.
27. LOFBERG, H.; GRUBB, A.O. Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest, v. 39, p. 619-26, 1979.
28. CHANG, B.S. Red cell morphology as a diagnostic aid in hematuria. JAMA, v. 252, p. 1747-9, 1984.
29. BIRCH, D.F.; FAIRLEY, K.F. Haematuria: glomerular or non-glomerular? Lancet, v. 20, p. 845-46, 1979.
30. BIRCH, D.F. et al. Urinary erythrocyte morphology in the diagnosis of glomerular hematuria. Clin Nephrol, v. 20, p. 78-84, 1983.
31. FASSETT, R.G.; HORGAN, B.A.; MATHEW, T.H. Detection of glomerular bleeding by phase-contrast microscopy. Lancet, v. 26, p. 1432-4, 1982.
32. KOHLER, H.; WANDEL, E.; BRUNCK, B. Acanthocyturia: a characteristic marker for glomerular bleeding. Kidney Int, v. 40, p. 115-20, 1991.
33. HEINE, G.H. et al. Acanthocytes in the urine: useful tool to differentiate diabetic nephropathy from glomerulonephritis? Diabetes Care, v. 27, p. 190-94, 2004.
34. AMERICAN DIABETES ASSOCIATION. Diabetic nephropathy (position statement). Diabetes Care, v. 25, p. S85-89, 2002.
35. STUVELING, E.M. et al. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension, v. 43, p. 791-6, 2004.
36. MOGENSEN, C.E.; CHRISTENSEN, C.K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med, v. 311, p. 89-93, 1984.
37. GERSTEIN, H.C. et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA, v. 286, p. 421-26, 2001.
38. SCHRADER, J. et al. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J Hypertens, v. 24, p. 541-48, 2006.
39. ROMUNDSTAD, S. et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis, v. 42, p. 466-73, 2003.
40. KLAUSEN, K.P. et al. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension, v. 46, p. 33-37, 2005.
41. COMPER, W.D. et al. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int, v. 65, p. 1850-5, 2004.
42. HEWITT, S.M.; DEAR, J.; STAR, R.A. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol, v. 15, p. 1677-89, 2004.
43. KAMIJO, A. et al. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. J Lab Clin Med, v. 145, p. 125-33, 2005.
44. KAMIJO, A. et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int, v. 62, p. 1628-37, 2002.